Pharmacokinetics and pharmacodynamics of olopatadine following administration via nasogastric tube to healthy horses.
Abstract: To investigate the pharmacokinetics and antihistaminic effects (pharmacodynamics) of olopatadine in a small population of healthy horses after administration via nasogastric tube. Methods: 4 healthy adult Thoroughbreds. Methods: Olopatadine (0.1 mg/kg, once) was administered via nasogastric tube. Blood samples were collected at predetermined time points for pharmacokinetic analyses of the drug in plasma. Olopatadine effects were investigated by measurement of cutaneous wheals induced by ID histamine injection (0.1 mL [10 μg]/injection) at predetermined time points. Inhibition effect ratios were calculated on the basis of measured wheal size (area) after versus before olopatadine administration. Results: Mean ± SD maximum plasma olopatadine concentration was 48.8 ± 11.0 ng/mL approximately 1.5 hours after administration. Median terminal half-life was 6.11 hours. Mean ± SD maximal effect was 88.2 ± 4.9% inhibition approximately 3.5 hours after drug delivery, and the inhibition effect remained > 80% for 12.5 hours after treatment. No signs of adverse clinical effects were observed. Conclusions: Results suggested olopatadine may have a strong, long-term inhibitory effect against histamine-induced wheals in the skin of horses. Clinical research with a larger number of horses is warranted.
Publication Date: 2019-06-28 PubMed ID: 31246121DOI: 10.2460/ajvr.80.7.689Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Journal Article
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
The research conducted an investigation into the pharmacokinetics (the movement of drugs in the body) and pharmacodynamics (the study of the biological effects of drugs) of the drug olopatadine in healthy horses, finding it may provide a strong and long-lasting inhibitory effect against histamine-induced wheals in horse skin.
Study Details
- The researchers used 4 healthy adult Thoroughbreds for the experiment.
- Each horse was given a dose of olopatadine (0.1 mg/kg) via a nasogastric tube – a tube inserted through the nose and into the stomach.
Methodology
- After drug administration, blood samples were taken at predetermined intervals to track the concentration of the drug in the horse’s plasma.
- The effectiveness of olopatadine as an antihistamine was tested by causing wheals (swollen, itchy areas of skin) with an injection of histamine.
- Wheal sizes before and after olopatadine administration were compared to evaluate the drug’s inhibitory effects.
Results and Findings
- The mean maximum plasma olopatadine concentration was reached approximately 1.5 hours after administration at a level of 48.8 ± 11.0 ng/mL.
- The terminal half-life of olopatadine, or the time it takes for the drug concentration in the body to halve, was found to be around 6.11 hours on average.
- The drug was most effective around 3.5 hours after administration, showing an average inhibitory effect of 88.2 ± 4.9% on histamine-induced wheals.
- The observed inhibition effect remained above 80% for around 12.5 hours following drug administration.
- No adverse clinical effects were noted within the study’s scope.
Conclusions and Future Research
- The study concluded that olopatadine may potentially have a strong and long-lasting inhibitory effect on histamine-induced wheals in horse skin.
- However, the researchers indicated that further clinical research with a larger number of horses would help confirm and further investigate these findings.
Cite This Article
APA
Kuroda T, Nagata SI, Tamura N, Mita H, Kusano K, Mizobe F, Takizawa Y, Fukuda K, Kasashima Y.
(2019).
Pharmacokinetics and pharmacodynamics of olopatadine following administration via nasogastric tube to healthy horses.
Am J Vet Res, 80(7), 689-695.
https://doi.org/10.2460/ajvr.80.7.689 Publication
Researcher Affiliations
MeSH Terms
- Animals
- Female
- Histamine H1 Antagonists, Non-Sedating / pharmacokinetics
- Histamine H1 Antagonists, Non-Sedating / pharmacology
- Horses / metabolism
- Intubation, Gastrointestinal / veterinary
- Male
- Olopatadine Hydrochloride / pharmacokinetics
- Olopatadine Hydrochloride / pharmacology
Citations
This article has been cited 0 times.Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists